Zosano Pharma (ZSAN) IPO Opens Higher

Today's IPO for Zosano Pharma Corporation (Nasdaq: ZSAN) opened for trading at $11.66 after pricing 4,500,000 shares of common stock at a price to the public of $11.00 per share.

Ladenburg Thalmann and Roth Capital Partners are acting as joint book-running managers.

Zosano Pharma Corporation is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications. Zosano's microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, benefits that the company believes often are unavailable using oral formulations or injections. Zosano's microneedle patch system has the potential to deliver numerous medications for a wide variety of indications in commercially attractive markets. It has been tested in more than 400 patients with over 30,000 patches successfully applied to humans in Phase 1 and Phase 2 clinical studies.

You May Also Be Interested In